Document:

Exhibit 10.3

 

配偶同意函

 

SPOUSAL CONSENT

 

		致:	北京众巢众行科技有限公司

众巢医学科技(上海)有限责任公司

杨伟光

上海行众投资管理合伙企业(有限合伙)

 

		To:	Beijing Zhongchao
                                         Zhongxing Technology Co. Ltd.

Zhongchao Medical Technology
(Shanghai) Co., Ltd.

Weiguang Yang

Shanghai Xingzhong Investment
Management LP, Ltd.

 

本人,       郑志华       ,为杨伟光的合法配偶。本人在此无条件并不可撤销地同意杨伟光于2020年  9  月  10  日签署《业务合作协议》《独家购股权协议》《股权质押协议》《委托协议及授权委托书》(合称“VIE协议”),并同意按照上述协议的规定处置杨伟光持有的、并登记在其名下的众巢医学科技(上海)有限责任公司(“可变利益实体”)股权。

 

I,       Zhihua  Zheng      ,
am the lawful spouse of Weiguang Yang. I hereby consent unconditionally and irrevocably that a certain percentage of the shares
in Zhongchao Medical Technology (Shanghai) Co., Ltd. (“Variable Interest Entity”) that is held by and registered
in the name of my spouse, Weiguang Yang, will be disposed of pursuant to the arrangements under the Variable Interest Entity agreements
(including the Business Cooperation Agreement, the Exclusive Option Agreement, the Equity Interest Pledge Agreement and the Proxy
Agreement and Power of Attorney, which were executed by my spouse at    September 10th  ,
2020 (the “VIE Agreements”).

 

    1
                                         / 3

     

    

 

本人承诺不就杨伟光持有的可变利益实体的股权提出任何主张。本人进一步确认,杨伟光履行VIE协议以及进一步修改或终止VIE协议并不需要本人另行授权或同意。

 

I hereby undertake
not to make any assertions in connection with the equity interests of Variable Interest Entity which are held by Weiguang Yang.
I hereby further confirm that Weiguang Yang can perform the VIE Agreements and further amend or terminate the VIE Agreements absent
authorization or consent from me.

 

本人承诺将签署一切必要的协议,并采取一切必要的行动,以确保(经不时修订的)VIE协议得到适当履行。

 

I hereby undertake
to execute all necessary documents and take all necessary actions to ensure appropriate performance of the VIE Agreements (as
amended from time to time).

 

本人同意并承诺,如本人由于任何原因获得杨伟光持有的可变利益实体的任何股权,则本人应受(经不时修订的)VIE协议和北京众巢众行科技有限公司(“外商独资企业”)和可变利益实体于2019年  8  月
  14  日签订的(经不时修订的)独家服务总协议的约束,并遵守作为可变利益实体的股东在(经不时修订的)VIE协议下的义务,且为此目的,一旦外商独资企业提出要求,本人应签署格式和内容基本与(经不时修订的)VIE协议和(经不时修订的)独家服务总协议相同的一系列书面协议。

 

I hereby agree and
undertake that if I obtain any equity interests of Variable Interest Entity which are held by Weiguang Yang for any reasons, I
shall be bound by the VIE Agreements and the Master Exclusive Service Agreement entered into between the Beijing Zhongchao Zhongxing
Technology Co. Ltd. (“WFOE”) and Variable Interest Entity as of August 14th , 2019 (as amended from time to
time) and comply with the obligations thereunder as a shareholder of Variable Interest Entity. For this purpose, upon the WFOE’s
request, I shall sign a series of written documents in substantially the same format and content as the VIE Agreements (as amended
from time to time) and Master Exclusive Service Agreement (as amended from time to time).

 

    2
                                         / 3

     

    

 

本配偶同意函中英文版本具有相同的效力。若中文和英文有不一致,以中文文本为准。

 

Both Chinese and English
versions of this Spousal Consent shall have equal validity. In case of any discrepancy between the English version and the Chinese
version, the Chinese version shall prevail.

 

	 	姓名:
	 	郑志华
	 	 
	 	Name:
	 	Zhihua Zheng
	 	 
	 	日期:2020年
    9 月 10 日
	 	Date:
    September 10, 2020

 

 

3 / 3Exhibit 10.4

 

业务合作协议

 

BUSINESS
COOPERATION AGREEMENT

 

本业务合作协议(“本协议”)由以下各方于2020年
     9       月      10     
日在上海订立:

 

This
Business Cooperation Agreement(the “Agreement”)is entered into in Shanghai as of September
10th , 2020 by and among the following parties:

 

		(1)	北京众巢众行科技有限公司(“外商独资企业”),一家根据中华人民共和国(“中国”)法律在中国北京注册成立的外商独资企业;和

 

Beijing
Zhongchao Zhongxing Technology Co.,Ltd. (the “WFOE”),
a wholly foreign-owned enterprise registered in Beijing, the People's Republic of China (“China”
or “PRC”), under the laws of China; and

 

		(2)	众巢医学科技(上海)有限公司(“众巢医学”),一家根据中国法律在中国上海注册成立的内资公司;和

 

Zhongchao
Medical Technology (Shanghai) Co., Ltd. (“Zhongchao”), a domestic company registered
in Shanghai, China, under the laws of China; and

 

		(3)	在附件1列明的每一方(以下单独称为“一名股东”,合称为“股东”)

 

Each
of the parties listed under Schedule 1 (each, a “Shareholder”
and collectively, the “Shareholders”)

 

(以上外商独资企业、众巢医学和每一位股东单独称为“一方”,合称为“各方”)
。

 

(Each
of the WFOE, Zhongchao and each of the Shareholders, a “Party”,
and collectively the “Parties”).

 

序言

 

RECITALS

 

		(1)	鉴于,外商独资企业在多种类型业务方面已经具备了相关专业能力和实践经验;

 

WHEREAS,
the WFOE engages in the business of and has the relevant expertise and practical experience in various areas;

 

		(2)	鉴于,众巢医学在中国从事医学领域内的技术开发和技术咨询等业务。

 

WHEREAS,
Zhongchao engages in the business of technology development and technology consultation and related business in the field of medicine;

 

    1 / 17

     

    

 

		(3)	鉴于,外商独资企业与众巢医学在2019年8月14日签署了一份《独家服务总协议》(“服务协议”),根据该协议众巢医学应向外商独资企业支付服务费;及

 

WHEREAS,
the WFOE has entered into a Master Exclusive Service Agreement (the “Service Agreement”)
dated August 14, 2019 with Zhongchao, pursuant to which the WFOE is entitled to receive service fees from Zhongchao; and

 

		(4)	鉴于,股东持有众巢医学100%的股权。

 

WHEREAS,
the Shareholders hold 100% equity interest in Zhongchao.

 

有鉴于此,基于本协议中包含的各项前提、声明、保证、承诺和约定,各方愿意受其法律约束,并达成如下约定:

 

NOW,
THEREFORE, in consideration of the premises and the representations, warranties, covenants and
agreements herein contained, and intending to be legally bound hereby, the Parties hereby agree as follows:

 

协议

 

AGREEMENT

 

		1.	不作为承诺

 

Negative
Covenants

 

为确保众巢医学履行其与外商独资企业所签服务协议和/或其他协议项下的义务,股东和众巢医学连带作出同意并承诺,未获外商独资企业的书面同意,众巢医学不得进行、股东亦应促使众巢医学不得进行,任何会对其资产、义务、权利或经营产生重大影响的交易,包括但不限于:

 

To
ensure that Zhongchao perform its obligations under the Service Agreement and/or other agreements executed with the WFOE, the
Shareholders and Zhongchao jointly and severally, agree and covenant that, without obtaining the WFOE’s written consent,
Zhongchao shall not, and the Shareholders shall cause Zhongchao not to, engage in any transaction which may materially affect
its asset, obligation, right or operation, including but not limited to:

 

		(a)	其各自正常业务范围未涵盖的活动,或从事与其过往经营不一致的业务活动;

 

Any
activities not within its normal business scope, or operating its business in a way that is inconsistent with its past practice;

 

		(b)	合并、整合、兼并、收购、和主要业务及资产的重组以及向任何企业或其他组织进行收购或投资,设立合营企业、合伙或其他类似经济组织;

 

Merger,
reorganization, acquisition or restructuring of its principal business or assets, or acquisition of or investment in any other
enterprise or entity, or formation of any joint venture, partnership or of other similar entity;

 

		(c)	向第三方提供、从第三方借入任何贷款、信贷或承担任何债务,但正常经营过程中发生的除外;

 

Offering
any loan to any third party, incurring any debt from any third party, or assuming any debt other than in the ordinary course of
business;

 

    2 / 17

     

    

 

		(d)	雇佣、变更或辞退任何董事或高管人员,制订或实施任何形式的员工激励计划,确定或更改高管薪酬;

 

Engaging,
changing or dismissing any director or any senior management officer, formulate or implement any staff motivation scheme, determining
or changing the salary of senior management officers;

 

		(e)	向第三方出售、或从第三方获得、抵押/质押、许可第三方使用或以其他方式处置任何有形或无形资产,但正常经营过程中发生的除外;

 

selling
to or acquiring from any third party, mortgaging, licensing or disposing of in other ways tangible or intangible assets, other
than in the ordinary course of business;

 

		(f)	发生、继承、担保或承受任何债务(但不包括在正常业务过程中发生的债务)或使用其资产向第三方提供担保以或其他形式提供保证,或在其资产上设置任何权利负担;

 

incurring,
inheriting, assuming or guaranteeing any debt that are not incurred during the ordinary course of business, using its assets to
provide security or other forms of guarantees to any third party, or setting up any other encumbrances over its assets;

 

		(g)	对其章程或其他组织性文件进行补充、变更或修改,增减其注册资本或通过其他方式变更其注册资本结构;

 

Making
any supplement, amendment or alternation to its articles of association or other constitutional documents, increasing or decreasing
of its registered capital or changing the structure of its registered capital in other manners;

 

		(h)	以任何方式进行股息、股权权益或股东权益的分配,但在外商独资企业书面要求时,众巢医学应立即向股东分配全部或部分可分配利润,然后再由股东立即并无条件地将上述分配支付或转移至外商独资企业;

 

Making
distribution of dividend or equity interest or shareholding interest in whatever ways, provided that upon the WFOE’s written
request, Zhongchao shall immediately distribute part or all distributable profits to its shareholder(s) who shall in turn immediately
and unconditionally pay or transfer to the WFOE any such distribution;

 

		(i)	签署任何重大合同,但在正常业务过程中签署的除外(就本段而言,重大合同的标准由外商独资企业自行判断);

 

Executing
any material contract, except the contracts executed in the ordinary course of business (for purpose of this subsection, the WFOE
may define a material contract at its sole discretion);

 

		(j)	通过任何方式出售、转让、抵押或处置其业务或收入中的法定或受益权益,或允许设置任何相关的担保权益或其他权利负担;

 

Selling,
transferring, mortgaging or disposing of in any manner any legal or beneficial interest in its business or revenues, or allowing
the encumbrance thereon of any security interest or any other encumbrance;

 

    3 / 17

     

    

 

		(k)	解散、清算和分配剩余财产;或

 

Dissolution,
conducting liquidation and distributing the residual assets; or

 

		(l)	促使其任何分支机构或子公司发生上述行为或签署任何可能导致上述行为发生
                                         的合同、协议或其他法律文件。

 

Causing
any of its branches or subsidiaries to engage in any of the foregoing or enter into any contract, agreement or other legal documents
which may lead to or result in any of the foregoing.

 

		2.	业务经营和人员安排

 

Business
Operation and Personnel Arrangement

 

		2.1	众巢医学同意并向外商独资企业承诺,众巢医学和股东将促使众巢医学:(1)接受外商独资企业就众巢医学的人员安排和调任、日常运营、股息分配和财务管理系统所提出的建议,且众巢医学将相应地严格遵守和履行;(2)谨慎、有效地经营众巢医学公司业务和处理公司事务,按照良好的财务和商业标准及实务维持众巢医学的存续;(3)在经营众巢医学全部业务的正常运营过程中,一直保持众巢医学的资产价值,不得采取任何可能影响众巢医学业务状况和资产价值的任何行为/不作为;(4)在外商独资企业提出要求时提供有关众巢医学业务经营和财务状况的相关资料;(5)如外商独资企业要求,为众巢医学的资产和业务从符合外商独资企业要求的保险公司处购买并持有保险,保险金额和险种应符合同类公司购买的金额和种类;(6)如发生或可能发生与众巢医学的资产、业务或收入相关的任何诉讼、仲裁或行政程序,立即通知外商独资企业;(7)为保持众巢医学对其全部资产的所有权,应签署全部必要或适当的文件,采取全部必要或适当的行为,提出全部必要或适当的控告,或针对全部索赔提出必要和适当的抗辩。

 

Zhongchao
agrees and covenants to the WFOE that Zhongchao
shall, and the Shareholders shall cause Zhongchao to, (i) accept suggestions raised
by the WFOE over the employee engagement and replacement, daily operation, dividend distribution and financial management systems
of Zhongchao, and Zhongchao shall strictly abide
by and perform accordingly; (ii) maintain Zhongchao’s corporate existence in accordance
with good financial and business standards and practices by prudently and effectively operating its business and handling its
affairs; (iii) operate all of Zhongchao’s businesses during the ordinary course
of business to maintain the asset value of Zhongchao and refrain from any action/omission
that may adversely affect Zhongchao’s operating status and asset value; (iv) provide
the WFOE with information on Zhongchao’s business operations and financial condition
at WFOE’s request; (v) if requested by the WFOE, procure and maintain insurance in respect of Zhongchao’s
assets and business from an insurance carrier acceptable to the WFOE, at an amount and type of coverage typical for companies
that operate similar businesses; (vi) immediately notify the WFOE of the occurrence or possible occurrence of any litigation,
arbitration or administrative proceedings relating to Zhongchao’s assets, business
or revenue; and (vii) execute all necessary or appropriate documents, take all necessary or appropriate actions and file all necessary
or appropriate complaints or raise necessary and appropriate defenses against all claims so as to maintain the ownership by Zhongchao
of all of its assets.

 

    4 / 17

     

    

 

		2.2	股东应仅指派由外商独资企业指定的人员作为众巢医学的董事,具体程序按相关法律、法规和公司章程规定进行。众巢医学应促成外商独资企业指定的人员担任众巢医学的总经理、首席财务官和其他高级管理人员职务。

 

The
Shareholders shall only appoint persons designated by the WFOE to be the directors of Zhongchao
in accordance with the procedures required by laws, regulations and relevant articles of association. Zhongchao
shall cause the persons designated by the WFOE to be the general manager, chief financial officer and other senior management
members of Zhongchao.

 

		2.3	若外商独资企业指定的上述董事或高级管理人员辞职,或应外商独资企业的要求被辞退,股东、众巢医学应根据外商独资企业的要求将该名人员从众巢医学辞退,且应指派外商独资企业指定的其他人选继任该职位。

 

If
any of the above directors or senior management members designated by the WFOE resigns from the relevant position or is dismissed
at the request of the WFOE, the Shareholders or Zhongchao, as the case may be, shall
dismiss such person from Zhongchao upon the WFOE’s request, and shall appoint any
other person designated by the WFOE to hold such position.

 

		2.4	众巢医学及其股东在此连带向外商独资企业承诺并与其约定,在根据众巢医学相关的内部审批政策签署任何重大合同(“重大”之定义由外商独资企业予以确定)之前,众巢医学应获得外商独资企业的相应批准。

 

Zhongchao
together with its Shareholders hereby jointly
and severally covenant to and agree with the WFOE that Zhongchao shall seek appropriate
approval from the WFOE prior to entering into any material contract (the definition of “material” shall be determined
by the WFOE) in accordance with relevant internal approval policy of Zhongchao.

 

		3.	其他安排

 

Other
Arrangements

 

鉴于(1)外商独资企业及其关联方已通过服务协议与众巢医学建立了业务关系,且(2)众巢医学进行的日常业务活动,将对众巢医学向外商独资企业或其关联方支付服务费用的能力产生重大影响,股东同意,除非外商独资企业要求:

 

Given
(i) that the business relationship between the WFOE (together with its affiliates) and Zhongchao
has been established through the Service Agreement and (ii) that the daily business activities of Zhongchao
will have a material impact on Zhongchao’s ability to pay the payables to
the WFOE or its affiliates, the Shareholders agree that, unless required by the WFOE:

 

		(a)	不得提出或投票赞成任何股东决议、或以其他方式要求众巢医学向其任何股东分配任何利润、资金、资产或财物;及

 

They
shall not put forward, or vote in favor of, any shareholder resolution to, or otherwise request Zhongchao
to, distribute any profits, funds, assets or property to the Shareholders of Zhongchao;
and

 

    5 / 17

     

    

 

		(b)	不得提出或投票赞成任何股东决议、或以其他方式要求众巢医学就股东所持的股权分派任何股息或进行其他方式的分配;但若众巢医学向股东进行股息分配或以
                                         其他方式进行分配,股东应于分配发生时立即且无条件向外商独资企业支付或转让其作为众巢医学的股东从众巢医学获得的任何股息或其他分配,并应在未经外商独资企业事先书面同意便向股东派发股息或进行其他分配的情况下承担该等股息与分配转让或支付给外商独资企业所产生的一切税费(包括外商独资企业被征收的税费)。

 

			They
shall not put forward, or vote in favor of, any shareholder resolution to, or otherwise request Zhongchao
to, issue any dividends or other distributions with respect to the equity interest of Zhongchao
held by the Shareholders; provided, however, if any dividends or other distributions are distributed to the Shareholders
by Zhongchao, the Shareholders shall immediately and unconditionally pay or transfer to the WFOE any and all dividends or other
distributions in whatsoever form obtained from Zhongchao as shareholders of Zhongchao
at the time such distributions arise, and the Shareholders shall bear any and all taxes and fees with respect to such transfer
of dividends and distributions to the WFOE (including the taxes and fees imposed on the WFOE) in the event such dividends or distributions
are paid to the Shareholders without the WFOE’s prior written consent.

 

		4.	转让

 

Assignments

 

未获外商独资企业的事先书面同意,股东和众巢医学不得向任何第三方转让其各自在本协议项下的权利和义务。股东和众巢医学在此共同同意,外商独资企业可以其完全自主判断自行转让其在本协议下的权利和义务,且仅需向众巢医学和股东发出书面通知。

 

The
Shareholders and Zhongchao shall not assign their respective rights and obligations under
this Agreement to any third party without the prior written consent of the WFOE. The Shareholders and Zhongchao
hereby jointly agree that the WFOE may assign its rights and obligations under this Agreement as the WFOE may decide at
its sole discretion and such transfer shall only be subject to a written notice sent to Zhongchao
and the Shareholders.

 

本协议规定的权利和义务对各方的受让人、继承人、配偶、监护人、债权人或者任何其他有权对众巢医学之股权主张权利或者利益的其他人具有法律约束力,且无论该等权利和义务的转让是由接管、重组、继承、转让、死亡、丧失行为能力、破产、离婚或其他原因导致。

 

Rights
and obligations under this Agreement shall be legally binding upon any assignees, successors, spouse, guardians and creditors
of the Parties hereof or any other person that may be entitled to assume rights and interests in the equity interest of Zhongchao,
no matter such assignment of obligations and rights is caused by takeover, restructuring, succession, assignment, death, incapacity,
bankruptcy, divorce or any other reason.

 

		5.	完整协议和协议修改

 

Entire
Agreement and Amendment to Agreement

 

		5.1	本协议及本协议中明确提及或包含的全部约定和/或文件构成关于本协议标的事项的完整协议,并取代各方此前就本协议标的事项达成的所有口头约定、合同、谅解和交流。

 

This
Agreement and all agreements and/or documents mentioned or included explicitly by this Agreement constitute the complete agreement
with respect to the subject matter of this Agreement and shall supersede any and all prior oral agreements, contracts, understandings
and communications made by the Parties with respect to the subject matter of this Agreement.

 

    6 / 17

     

    

 

		5.2	对本协议的任何修改应以书面方式作出,并仅在本协议各方签署后方生效。由各方正式签署的修改协议或补充协议构成本协议的组成部分,与本协议具有同等法律效力。

 

Any
modification of this Agreement shall be made in a written form and shall only become effective upon execution by all Parties of
this Agreement. Modifications and supplements to this Agreement duly executed by the Parties shall be parts of this Agreement
and shall have the same legal effect as this Agreement.

 

		6.	陈述和保证

 

Representations
and Warranties

 

		6.1	外商独资企业特此作出如下陈述和保证:

 

The
WFOE hereby represents and warrants as follows:

 

		(a)	其是依照中国法律正式注册设立并有效存续的一家外商独资企业;

 

It
is a wholly foreign-owned enterprise duly incorporated and validly existing under PRC law;

 

		(b)	其于公司权力和营业范围之内签署并履行本协议。其已采取必要的公司行为且获得适当授权,并已从第三方和政府部门获得必要的同意及批准。外商独资企业签署并履行本协议不会违反法律或对其有约束力的合同;及

 

Its
execution and performance of this Agreement are within its corporate power and business scope. It has taken necessary corporate
actions and obtained appropriate authorizations, and has obtained the necessary consents and approvals from any third parties
and government agencies. Its execution and performance of this Agreement do not violate the laws and contracts binding upon it;
and

 

		(c)	本协议一经签署即构成对外商独资企业合法、有效、有约束力的义务,并依本协议之条款可对其强制执行。

 

Upon
execution, this Agreement will constitute a legal, valid and binding obligation of the WFOE enforceable against the WFOE in accordance
with its terms.

 

		6.2	众巢医学特此作出如下陈述和保证:

 

Zhongchao
hereby represents and warrants as follows:

 

		(a)	其是依照中国法律正式注册设立并有效存续的法人;

 

It
is a legal person duly incorporated and validly existing under PRC law;

 

    7 / 17

     

    

 

		(b)	其于公司权力和营业范围之内签署并履行本协议。其已采取必要的公司行为且获得适当授权,并已从第三方和政府部门获得必要的同意及批准。其签署并履行本
                                         协议不会违反法律或对其有约束力的合同;及

 

Its
execution and performance of this Agreement are within its entity power and business scope. It has taken necessary entity actions
and obtained appropriate authorizations, and has obtained the necessary consents and approvals from any third parties and government
agencies. Its execution and performance of this Agreement do not violate the laws and contracts binding upon it; and

 

		(c)	本协议一经签署即构成对其合法、有效、有约束力的义务,并依本协议之条款可对其强制执行。

 

Upon
execution, this Agreement will constitute a legal, valid and binding obligation of Zhongchao enforceable against Zhongchao in
accordance with its terms.

 

		6.3	股东特此作出如下陈述和保证:

 

The
Shareholders hereby represents and warrants as follows:

 

		(a)	其于本协议签订之日,合法有效的拥有众巢医学的股权,有充分的权利和授权签署本协议。其签署并履行本协议不会违反法律或对其有约束力的合同;及

 

It
has a valid and effective right to hold the shares of Zhongchao at the date of this Agreement and has full rights and authorizations
to enter into this Agreement. Its execution and performance of this Agreement do not violate the laws and contracts binding upon
it; and

 

		(b)	本协议一经签署即构成对其合法、有效、有约束力的义务,并依本协议之条款可对其强制执行。

 

Upon
execution, this Agreement will constitute a legal, valid and binding obligation of the Shareholders enforceable against the Shareholders
in accordance with its terms.

 

		7.	保密

 

		7.1	各方承认,各方就本协议交换的任何口头或书面信息均属于保密信息。每一方应对上述全部信息保密,在未取得其他方的书面同意前,不得向任何第三方披露任何相关信息,但下述情况除外:(a)该信息已经或将被公众所知(但不是因为接受一方的违约披露导致的);(b)按照适用法律、法规或证券交易所的要求披露的;或(c)任何一方需要向其法律顾问、财务顾问、董事或高级管理人员披露的有关本协议项下拟定交易的信息,且该法律顾问、财务顾问、董事或高级管理人员受与本款规定相类似的保密义务的制约。如任何一方聘用的任何职员或代理机构披露保密信息,将被视为该方披露了该保密信息并因此承担违约责任。本款规定将在本协议因任何原因终止后持续有效。

 

The
Parties acknowledge that any oral or written information exchanged among them with respect to this Agreement is confidential information.
Each Party shall maintain the confidentiality of all such information, and without obtaining the written consent of other Parties,
it shall not disclose any relevant information to any third parties, except in the following circumstances: (a) such information
is or will be in the public domain (provided that this is not the result of a public disclosure by the receiving party); (b) information
disclosed as required by applicable laws or regulations or rules of any securities exchange; or (c) information required to be
disclosed by any Party to its legal counsel, financial advisor, directors or senior management officers regarding the transaction
contemplated hereunder, provided that such legal counsel, financial advisor, directors or senior management officers is also bound
by confidentiality duties similar to the duties set out in this section. Disclosure of any confidential information by the staff
members or agency hired by any Party shall be deemed disclosure of such confidential information by such Party, which Party shall
be held liable for breach of this Agreement. This Section shall survive the termination of this Agreement for any reason.

 

    8 / 17

     

    

 

		7.2	各方同意本协议终止或失效时,本条仍然有效。

 

The
Parties agree that this section shall remain survive the termination or expiration of this Agreement.

 

		8.	管辖法律

 

Governing Law

 

本协议受中国法律管辖且据其进行解释。

 

This
Agreement shall be construed in accordance with and governed by the laws of China.

 

		9.	争议解决

 

Dispute
Resolution

 

因本协议产生或与本协议相关的任何争议或主张应由各方通过友好协商的方式解决。如果各方未能解决争议,应将争议提交到上海国际经济贸易仲裁委员会(“仲裁委”),由仲裁会按照申请仲裁时有效的仲裁委仲裁规则经由仲裁解决。仲裁地为上海,仲裁语言为中文。只用一名仲裁员仲裁,该仲裁员由仲裁委指定。仲裁裁决具终局性且对各方都有约束力。

 

Any
dispute or claim arising out of or in connection with or relating to this Agreement shall be resolved by the Parties in good faith
through negotiations. In case no resolution can be reached by the Parties, such dispute shall be submitted to the Shanghai International
Economic and Trade Arbitration Commission (the “Arbitration Commission”) for arbitration in accordance with
its rules of arbitration in effect at the time of applying for such arbitration and the place of arbitration shall be in Shanghai,
and the language of arbitration shall be Chinese. The arbitration tribunal shall be composed of only one arbitrator, which shall
be appointed by the arbitration commission. The arbitral award shall be final and binding upon all Parties.

 

在争议解决和仲裁程序进行过程中,除了本协议正在仲裁的事宜以外,各方应在实际可行的前提下继续履行本协议。每一方应自行承担为解决任何争议而发生的费用,但仲裁费应由各方平均分担。

 

Throughout
any dispute resolution and arbitration proceedings, the Parties shall continue to perform this Agreement, to the extent practical,
with the exception of the matter that is under arbitration. Each Party shall be responsible for its own expenses in connection
with resolving any Dispute, but the arbitration fees shall be shared equally.

 

    9 / 17

     

    

 

		10.	损害赔偿

 

Indemnities
and Remedies

 

		10.1	如一方存在以下情形,则该方应就该等情形给另一方造成的损失、损害、责任、被索赔损失等(包括合理的律师费,“损失”)依照另一方的要求立即予以赔偿,以使另一方免受损失:(1)该一方在本协议中所作的任何陈述或保证不真实、不准确或不完整,或者(2)该一方违反了其在本协议中所作的任何陈述或保证,或者(3)该一方违反了其在本协议中任何约定或承诺;但如果另一方遭受的损失系由于该另一方或该另一方的董事、管理人员、雇员或者代理人自身的故意行为不当、违反法律、违约行为、重大过失等原因造成的,则违约方无需对另一方予以赔偿。

 

Either
Party shall forthwith on demand indemnify and hold harmless the other Party against any claim, loss, liability or damage (including
reasonable legal fees, “Loss”) which the other such Party shall suffer due to any of the following circumstances:
(i) any of the representations or warranties herein made by such Party is untrue, inaccurate or incomplete, or (ii) such Party
breaches any of its representations or warranties herein, or (iii) such Party breaches any covenant or undertaking herein; provided
that neither Party shall be liable to indemnify the other Party for any Loss to the extent that such Loss arises from the willful
misconduct, breach of applicable law, regulation or contractual obligation or from the material negligence of the other Party
or its directors, officers, employees, or agents.

 

		10.2	各方同意本协议终止或失效时,本条仍然有效。

 

The
Parties agree that this section shall remain survive the termination or expiration of this Agreement.

 

		11.	生效日和期限

 

Effective
Date and Term

 

		11.1	本协议应于文首所载日期签署并生效。

 

This
Agreement shall be signed and take effect as of the date first set forth above.

 

		11.2	本协议在众巢医学存续期间持续有效,除非根据第12条规定终止。

 

This
Agreement shall remain effective as long as Zhongchao exists unless terminated as provided
in Section 12.

 

		12.	终止

Termination

 

		12.1	股东和众巢医学均不得终止本协议。本协议在以下任何情况下终止:(1)外商独资企业可随时以提前三十(30)天书面通知众巢医学和股东的方式终止本协议;(2)根据《独家购股权协议》,股东持有的众巢医学之股权已转让给外商独资企业和/或外商独资企业指定的第三方,本协议于该等转让完成时终止。

 

Neither
of the Shareholders and Zhongchao shall have the right to terminate this Agreement. This
Agreement shall be terminated (i) by the WFOE at any time with thirty (30) days advance written notice to Zhongchao and
the Shareholders; or (ii) upon the transfer of the equity interest held by the Shareholders to the WFOE and/or a third party
designated by the WFOE pursuant to the Exclusive Option Agreement, this Agreement shall be terminated on the day of
completion of this transfer.

 

    10 / 17

     

    

 

		13.	通知

 

Notices

 

		13.1	任何一方按本协议规定发出的通知或其他通信应以英文或中文书写,并可以专人递送、挂号邮寄、邮资预付邮寄、或受承认的专递服务或发送传真的形式发送到有关各方不时指定的收件地址。通知被视为实际送达的日期,应按如下方式确定:(a)专人递送的通知,专人递送当日即视为已实际送达;(b)用信函发出的通知,则在邮资付讫的航空挂号信寄出日(依邮戳为准)后的第十(10)天,即视为已实际送达,或在送交专递服务公司后的第四(4)天,即视为已实际送达;以及(c)用传真发送的通知,在有关文件的传送确认单上所显示的接收时间,即视为已实际送达。

 

Notices
or other communications required to be given by any party pursuant to this Agreement shall be written in English and Chinese and
delivered personally or sent by registered mail or postage prepaid mail or by a recognized courier service or by facsimile transmission
to the address of each relevant party as specified by such party from time to time. The date when a notice is deemed to be duly
served shall be determined as follows: (a) a notice delivered personally is deemed duly served upon delivery; (b) a notice sent
by mail is deemed duly served on the tenth (10th) day after the date when the postage prepaid registered airmail is posted (as
evidenced by the postmark), or on the fourth (4th) day after the date when the notice is delivered to an internationally-recognized
courier service agency; and (c) a notice sent by facsimile transmission is deemed duly served upon receipt as evidenced by the
time shown in the transmission confirmation for the relevant documents.

 

		14.	可分割性

 

Severability

 

如果本协议项下的任何条款因与有关法律不一致而无效或不可执行,则该条款仅在有关法律的管辖范围之内被视为无效或不可执行,并且本协议其他条款的有效性,合法性和可强制执行性不受其影响。

 

If
any provision of this Agreement is judged to be invalid or unenforceable because it is inconsistent with applicable laws, such
invalidity or unenforceability shall be only with respect to such laws, and the validity, legality and enforceability of the other
provisions hereof shall not be affected.

 

		15.	转让

 

Assignment

 

		15.1	未经外商独资企业事先书面同意,众巢医学和股东不得将其在本协议项下的权利和义务转让给任何第三方。

 
Zhongchao
                                         and the Shareholders shall not assign any of its rights or obligations under this Agreement
                                         to any third party without the prior written consent of the WFOE.

 

    11 / 17

     

    

 

		15.2	众巢医学和股东在此同意,外商独资企业可转让其在本协议项下的权利和义务。外商独资企业仅需就该转让向众巢医学和股东发出书面通知。

 

Zhongchao
and the Shareholders hereby agrees that the WFOE
may assign its rights and obligations under this Agreement, only subject to a written notice to Zhongchao
and the Shareholders.

 

		15.3	本协议的条款和条件应为当事方各自的继承人和经许可的受让人之利益而生效,并应约束当事方各自的继承人和受让人。除非本协议明示规定,本协议的任何规定(明示和默示的)均不意图赋予除本协议当事方或其各自继承人和受让人之外的任何他方本协议项下或源于本协议的任何权利、救济、义务、或责任。

 

The
terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted
assigns of the Parties. Save as expressly provided in this Agreement, nothing in this Agreement, express or implied, is intended
to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations,
or liabilities under or by reason of this Agreement.

 

		16.	文本

Counterparts

 

本协议由协议各方签署四(4)份正本,所有正本具有同等法律效力。

 

This
Agreement shall be executed in four (4) originals. All originals shall have the same legal effect.

 

		17.	语言

Languages

 

本协议以英文和中文书就,英文文本和中文文本具有同等法律效力。若英文文本和中文文本有任何不一致的约定,以中文文本的相应内容为准。

 

This
Agreement is written in English and Chinese, both English and Chinese language versions of this Agreement shall have equal validity.
In case of any discrepancy between the English version and the Chinese version, the Chinese version shall prevail.

 

[后附签字页Signature
Pages Follow]

 

    12 / 17

     

    

 

有鉴于此,各方于文首所述日期正式签署本协议。

 

IN
WITNESS WHEREOF, the Parties have duly executed this Agreement on the date appearing at the head hereof.

 

北京众巢众行科技有限公司

 

Beijing
Zhongchao Zhongxing Technology Co., Ltd.

 

授权代表(Authorized
Representative):/s/ Weiguang Yang

 

    13 / 17

     

    

 

有鉴于此,各方于文首所述日期正式签署本协议。

 

IN
WITNESS WHEREOF, the Parties have duly executed this Agreement on the date appearing at the head hereof.

 

众巢医学科技(上海)有限公司

 

Zhongchao
Medical Technology (Shanghai) Co., Ltd.

 

授权代表(Authorized
Representative):/s/ Weiguang Yang.

 

    14 / 17

     

    

 

有鉴于此,各方于文首所述日期正式签署本协议。

 

IN
WITNESS WHEREOF, the Parties have duly executed this Agreement on the date appearing at the head hereof.

 

杨伟光

 

Weiguang
Yang

 

签字/Signature:/s/
Weiguang Yang.

 

    15 / 17

     

    

 

有鉴于此,各方于文首所述日期正式签署本协议。

 

IN
WITNESS WHEREOF, the Parties have duly executed this Agreement on the date appearing at the head hereof.

 

上海行众投资管理合伙企业(有限合伙)

 

Shanghai
Xingzhong Investment Management LP, Ltd.

 

授权代表(Authorized
Representative):/s/ Weiguang Yang.

 

    16 / 17

     

    

 

SCHEDULE
1

附件1

 

Shareholders

股东

 

	序号

        No.
	 	姓名

        Name
	 	证件号码/统一信用代码

        No.

	1.	 	杨伟光

        Weiguang
        Yang
	 	362227198206170314
	2.	 	上海行众投资管理合伙企业(有限合伙)

        Shanghai
        Xingzhong Investment Management LP, Ltd.
	 	913101143584694449

 

 

17 / 17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]